CYTOKINETICS INC (CYTK)
Healthcare · Pharmaceutical Preparations
CYTOKINETICS INC (CYTK) stock research on InvestAtlant: institutional ownership from 13F filings, insider Form 4 activity, and SEC context.
Top institutional holders (2026-Q2)
| Institution | Shares | Value | % Outstanding |
|---|---|---|---|
| BlackRock, Inc. | 20,094,362 | .71B | 14.45% |
| T. Rowe Price Investment Management, Inc. | 18,718,498 | .59M | 13.46% |
| WELLINGTON MANAGEMENT GROUP LLP | 6,931,770 | $590.52M | 4.99% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 6,711,799 | $571.78M | 4.83% |
| State Street Corp | 6,494,233 | $553.24M | 4.67% |
| VANGUARD CAPITAL MANAGEMENT LLC | 6,117,515 | $521.15M | 4.40% |
| FMR LLC | 5,031,782 | $428.66M | 3.62% |
| Avoro Capital Advisors LLC | 4,999,999 | $425.95M | 3.60% |
Recent insider transactions
| Date | Insider | Title | Type | Value |
|---|---|---|---|---|
| 2026-09-22 | Malik Fady Ibraham | EVP Research & Development | Sale | $239.0K |
| 2026-09-15 | Landry Robert E | Director | Sale | $72.1K |
| 2026-09-15 | Blum Robert I | President & CEO, Director | Sale | $6.79M |
| 2026-09-14 | Blum Robert I | President & CEO, Director | Sale | $550.8K |
| 2026-09-11 | Landry Robert E | Director | Sale | $74.7K |
| 2026-09-08 | Malik Fady Ibraham | EVP Research & Development | Sale | $264.1K |
| 2026-09-01 | PARSHALL B LYNNE | Director | Sale | $357.4K |
| 2026-08-31 | Blum Robert I | President & CEO, Director | Sale | $526.8K |